INDUSTRY INSIGHTS YOUR PEERS ARE READING
Cannabis Featured Medical Marijuana News Politics DEA fentanyl opioid crisis white houseWhy Is The White House Lying About Marijuana And Fentanyl? MORE
As the year ends we can only hope that 2019 will see the removal of cannabis from the DEA’s controlled substance list. Industry MORE
For those unfamiliar with the story, Rhonda and her late husband Larry’s property in Washington State, near the town of Kettle Falls was raided in 2012 by the Drug Enforcement Administration (DEA) for growing medical cannabis The last 5 years have been a nightmare for Rhonda Firestack-Harvey, who is well known among medical cannabis advocates as a member of the Kettle Falls Five. MORE
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
I think the prevailing view is that the plain language of the statute [the Farm Bill] intended for that, but I’m not sure that DEA has done that yet. DEA would have to formally de-schedule CBD derived from hemp.”. MORE
On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA). MORE
Unfortunately, CBD is still labeled as high potential for abuse by the DEA. While it is legal medically in California, unfortunately, federally it is not legal and classified in the same drug category as heroin to the DEA. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. The case now remains in the DEA’s hands until further notice. Getting involved matters. MORE
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim. MORE
Marijuana Moment reports. The House Rules Committee published the submitted measures on Thursday. MORE
Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status. MORE
Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S. MORE
Sacramento New & Review have detailed the DEA, FBI and IRS investigations and written a piece well worth reading if you want to understand how difficult it is going to be to dig out the entrenched black sector of cannabis in California. MORE
While hemp is no longer a controlled substance and subject to enforcement under DEA regulations, hemp and hemp-derived products (such as CBD) are still heavily regulated. MORE
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry. MORE
He uses his past experience as a Marine Corps federal prosecutor, DEA Drug Task Force Commander and Colorado state narcotics prosecutor to assist his clients in establishing strict regulatory compliance protocols at both the state, federal and international levels. MORE
Military.com reports. During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA. MORE
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3% On Monday, the U.S. MORE
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. ” Although that ruling ordered DEA to lift the ban, the agency failed to do so. MORE
Court of Appeals for the District of Columbia to order the DEA to process the applications. “We We are still working through the process and those applications remain under review,” said DEA spokeswoman Katherine Pfaff in an email Thursday. The U.S. MORE
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval? MORE
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue. MORE
The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA. The FDA news implied that it will recommend CBD be rescheduled, but acknowledged the act of shifting its legality is ultimately up to the DEA. MORE
A snapshot taken directly from the Drug Enforcement Agency (DEA) website is reproduced below: Schedule I: Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. MORE
Cannabis Medical Marijuana News DEA marijuana research NIDAThe National Institute of Drug Abuse announced plans to grow the largest crop of research marijuana in five years. Continue reading Is The Federal Government Finally Serious About Marijuana Research? at The Fresh Toast. MORE
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast. MORE
Accordingly, the USDA held that the DEA “no longer has authority to require hemp seed permits for import purposes.”. According to the Montana senator, the DEA was blocking Montana farmers from importing hemp seeds. Here come the hemp seeds! Last Friday, the U.S. MORE
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. Here, DEA can act with little expenditure of resources.”. MORE
Drug Enforcement Administration (DEA) to reschedule cannabis, before filing suit. In July 2017, four medical cannabis patients joined other advocates in filing a lawsuit against the federal government in the U.S. District Court for the Second District of New York. MORE
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. MORE
Nobody wants to see someone in jail for a month for the wrong thing,” DEA spokeswoman Barbara Carreno said. “To PORTLAND — Federal legalization of hemp arrived in the U.S. MORE
“Nobody wants to see someone in jail for a month for the wrong thing,” DEA spokeswoman Barbara Carreno said. Some samples sent to a DEA lab in Washington, D.C., PORTLAND, Ore. Federal legalization of hemp arrived in the U.S. MORE
This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. MORE
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures MORE
Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. The DEA has routinely denied each petition, or declined to accept it outright. MORE
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. MORE
Food and Drug Administration (DEA), contains the active ingredient cannabidiol (CBD) but it does not contain psychoactive molecule THC, which generates the marijuana high. “We The DEA still classifies cannabis as a Schedule I drug with no recognized medical benefit, even though more than half the states have legalized cannabis in some form. Marijuana – it’s a numbers game. MORE
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” More recently, in 2016, the DEA changed its position and amended regulations in a manner to permit additional applicants to apply to federal licensure to grow marijuana. MORE
DEA Related Topics 
NORML
JULY 16, 2019
According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures
WeedAdvisor
JULY 4, 2019
Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. Here, DEA can act with little expenditure of resources.”.
Leafly
MARCH 22, 2019
The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.
CannaTech
JUNE 23, 2019
As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry.
WeedAdvisor
JUNE 1, 2019
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue.
Cannabis Law Report
JUNE 3, 2019
Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status.
|
Marijuana Lawyer Blog
JANUARY 12, 2019
Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?
MJ Business Attorneys
JUNE 29, 2018
Moreover, the ball is in the Drug Enforcement Agency’s (DEA) court. The FDA can make recommendations to the DEA about substances subjected to scheduling under the CSA, but the DEA is the entity with the power to reschedule CBD. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3% On Monday, the U.S.
NORML
MARCH 1, 2019
” Last year, however, former DEA director Robert Patterson testified to Congress that the agency believed that approving additional applicants would likely violate international anti-drug treaties. Patterson said that DEA could not move forward granting any new applications until the Justice Department clarified the issue. ” Although that ruling ordered DEA to lift the ban, the agency failed to do so.
The Fresh Toast
APRIL 2, 2019
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health.
|
|
The Fresh Toast
JULY 15, 2019
Cannabis Medical Marijuana News DEA marijuana research NIDAThe National Institute of Drug Abuse announced plans to grow the largest crop of research marijuana in five years. Continue reading Is The Federal Government Finally Serious About Marijuana Research? at The Fresh Toast.
The Fresh Toast
MARCH 28, 2019
Cannabis Featured Medical Marijuana News Politics DEA fentanyl opioid crisis white houseWhy Is The White House Lying About Marijuana And Fentanyl?
Cannabis Law Report
MAY 2, 2019
Military.com reports. During a hearing Tuesday on eight VA health-related bills under consideration by Congress, VA officials told House lawmakers that as long as marijuana is illegal under federal law, the department cannot support legislation that promotes its role at the VA.
The Fresh Toast
APRIL 2, 2019
Cannabis Medical Marijuana News RX DEA eyedrops FDA Glaucoma stoners THC topicalsGlaucoma And Medical Marijuana: 5 Informative Facts Medical marijuana glaucoma treatment can help reduced eye pressure and relieve pain. Here's what you need to know about using cannabis for eye health. The post Glaucoma And Medical Marijuana: 5 Informative Facts appeared first on The Fresh Toast.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
Project CBD
JULY 31, 2018
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
United Patients Group
AUGUST 21, 2017
Critics have claimed for decades that cannabis is a “gateway drug.” Proponents of prohibition argue that using cannabis will lead people to consume cocaine, heroin, or methamphetamine. Yet, no evidence exists to verify this claim.
NORML
JANUARY 17, 2019
As the result of a lawsuit, DEA Administrative Law Judge Mary Ellen Bittner in 2007 ruled that expanding the pool of federally licensed providers would be “in the public interest.” More recently, in 2016, the DEA changed its position and amended regulations in a manner to permit additional applicants to apply to federal licensure to grow marijuana.
Cannabis Law Report
JUNE 16, 2019
Marijuana Moment reports. The House Rules Committee published the submitted measures on Thursday.
The Fresh Toast
MARCH 27, 2019
Cannabis Maven
DECEMBER 31, 2018
As the year ends we can only hope that 2019 will see the removal of cannabis from the DEA’s controlled substance list. Industry
Americans for Safe Access
OCTOBER 17, 2017
On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA).
The Herb Collective
MARCH 30, 2018
Unfortunately, CBD is still labeled as high potential for abuse by the DEA. While it is legal medically in California, unfortunately, federally it is not legal and classified in the same drug category as heroin to the DEA.
Burns Levinson (Cannabusiness advisory)
OCTOBER 3, 2018
This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval.
Canna Law Blog
MARCH 30, 2019
I think the prevailing view is that the plain language of the statute [the Farm Bill] intended for that, but I’m not sure that DEA has done that yet. DEA would have to formally de-schedule CBD derived from hemp.”.
Americans for Safe Access
JUNE 6, 2019
Drug Enforcement Administration (DEA) to reschedule cannabis, before filing suit. In July 2017, four medical cannabis patients joined other advocates in filing a lawsuit against the federal government in the U.S. District Court for the Second District of New York.
Canna Law Blog
APRIL 25, 2019
Accordingly, the USDA held that the DEA “no longer has authority to require hemp seed permits for import purposes.”. According to the Montana senator, the DEA was blocking Montana farmers from importing hemp seeds. Here come the hemp seeds! Last Friday, the U.S.
PrestoDoctor
JULY 16, 2019
The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress. The case now remains in the DEA’s hands until further notice. Getting involved matters.
Cannabis Law Report
APRIL 18, 2019
Sacramento New & Review have detailed the DEA, FBI and IRS investigations and written a piece well worth reading if you want to understand how difficult it is going to be to dig out the entrenched black sector of cannabis in California.
Americans for Safe Access
NOVEMBER 17, 2017
For those unfamiliar with the story, Rhonda and her late husband Larry’s property in Washington State, near the town of Kettle Falls was raided in 2012 by the Drug Enforcement Administration (DEA) for growing medical cannabis The last 5 years have been a nightmare for Rhonda Firestack-Harvey, who is well known among medical cannabis advocates as a member of the Kettle Falls Five.
Garvey Schubert Barer - Cannabis Business
APRIL 1, 2019
While hemp is no longer a controlled substance and subject to enforcement under DEA regulations, hemp and hemp-derived products (such as CBD) are still heavily regulated.
MedicalJane
JUNE 29, 2018
The Next Move Is On The DEA. Epidiolex’s launch is in the hands of the DEA. The FDA news implied that it will recommend CBD be rescheduled, but acknowledged the act of shifting its legality is ultimately up to the DEA.
The Joint Blog
JULY 12, 2019
Court of Appeals for the District of Columbia to order the DEA to process the applications. “We We are still working through the process and those applications remain under review,” said DEA spokeswoman Katherine Pfaff in an email Thursday. The U.S.
Cannabis Law Report
JULY 7, 2019
A snapshot taken directly from the Drug Enforcement Agency (DEA) website is reproduced below: Schedule I: Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse.
Cannabis Chronicles
MARCH 29, 2019
Nobody wants to see someone in jail for a month for the wrong thing,” DEA spokeswoman Barbara Carreno said. “To PORTLAND — Federal legalization of hemp arrived in the U.S.
MJ Business Attorneys
DECEMBER 11, 2018
He uses his past experience as a Marine Corps federal prosecutor, DEA Drug Task Force Commander and Colorado state narcotics prosecutor to assist his clients in establishing strict regulatory compliance protocols at both the state, federal and international levels.
Puff Puff Post
APRIL 29, 2019
“Nobody wants to see someone in jail for a month for the wrong thing,” DEA spokeswoman Barbara Carreno said. Some samples sent to a DEA lab in Washington, D.C., PORTLAND, Ore. Federal legalization of hemp arrived in the U.S.
NewsMunchies
SEPTEMBER 5, 2018
Food and Drug Administration (DEA), contains the active ingredient cannabidiol (CBD) but it does not contain psychoactive molecule THC, which generates the marijuana high. “We The DEA still classifies cannabis as a Schedule I drug with no recognized medical benefit, even though more than half the states have legalized cannabis in some form. Marijuana – it’s a numbers game.
90 
Let's personalize your content